Posted on 27-Nov-2015 by Dr. Nadeem Khan
DMPK has become a tool to optimize ADME properties in drug designing and screening. However, there are many related questions that often boggle the mind of a drug developer.
Most importantly, there is a need to identify appropriate ADME tests required to conduct for preclinical studies. As a result, a few clarifications have become mandatory before initiating the ADME program
1. What should a representative IND package contain?
Typical IND enabling package includes... Continue Reading